RVL Pharmaceuticals PLC (OTC Pink - Limited Information:RVLPQ)
| 0.0031 Delayed Data As of Dec 08 |  -0.0004 / -11.43%Today’s Change | 0.00 Today|||52-Week Range 1.45 | -99.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | -- | -105.8M | -6.2M | -124.7M | |
| Depreciation | -- | 20.2M | 18.0M | 18.0M | ||
| Total Other Cash Flow | -- | 100.9M | 1.5M | 127.4M | ||
| Funds From Operations | -- | 10.9M | 11.9M | 10.2M | ||
| Funds From/For Other Operating Expenses | -- | -19.5M | 18.0M | 8.3M | ||
| Net Cash Flow - Operating Activities | -- | 30.4M | -6.1M | 2.0M | ||
| Investing | Capital Expenditures | -- | -1.1M | -634.6K | -1.5M | |
| Net Cash Flow Investing | -- | -1.1M | -634.6K | -1.5M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | -- | 1.8M | 0.00 | 1.3M | ||
| Long Term Debt Reduction | -- | -50.5M | -1.0M | -1.2M | ||
| Net Proceeds Stock Sale | -- | 58.1M | 0.00 | 0.00 | ||
| Common Preferred Redeemed | -- | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -- | 9.3M | -1.0M | 163.9K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | 55.7K | 0.00 | 0.00 | |
| Net Change In Cash | 0.00 | 38.6M | -7.8M | 675.3K | ||
